[PHARMA] QoQ TTM Result on 31-Dec-2016 [#4]

Announcement Date
21-Feb-2017
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2016
Quarter
31-Dec-2016 [#4]
Profit Trend
QoQ- -27.04%
YoY- -45.74%
Quarter Report
View:
Show?
TTM Result
30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 CAGR
Revenue 2,293,580 2,234,292 2,248,121 2,189,022 2,286,356 2,295,554 2,276,603 0.49%
PBT 57,267 61,919 73,256 72,017 91,665 97,079 100,648 -31.31%
Tax -25,268 -21,162 -26,609 -26,158 -28,865 -26,952 -29,520 -9.84%
NP 31,999 40,757 46,647 45,859 62,800 70,127 71,128 -41.25%
-
NP to SH 31,187 40,668 46,143 45,599 62,497 69,407 70,629 -41.98%
-
Tax Rate 44.12% 34.18% 36.32% 36.32% 31.49% 27.76% 29.33% -
Total Cost 2,261,581 2,193,535 2,201,474 2,143,163 2,223,556 2,225,427 2,205,475 1.68%
-
Net Worth 531,892 542,147 544,360 531,169 531,250 524,177 515,906 2.05%
Dividend
30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 CAGR
Div 41,490 38,883 41,456 41,442 51,803 64,750 69,935 -29.37%
Div Payout % 133.04% 95.61% 89.84% 90.88% 82.89% 93.29% 99.02% -
Equity
30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 CAGR
Net Worth 531,892 542,147 544,360 531,169 531,250 524,177 515,906 2.05%
NOSH 259,821 259,400 259,219 259,377 259,146 258,981 258,859 0.24%
Ratio Analysis
30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 CAGR
NP Margin 1.40% 1.82% 2.07% 2.09% 2.75% 3.05% 3.12% -
ROE 5.86% 7.50% 8.48% 8.58% 11.76% 13.24% 13.69% -
Per Share
30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 CAGR
RPS 883.98 861.33 867.27 844.83 882.26 886.38 879.48 0.34%
EPS 12.02 15.68 17.80 17.60 24.12 26.80 27.28 -42.06%
DPS 16.00 15.00 16.00 16.00 20.00 25.00 27.00 -29.42%
NAPS 2.05 2.09 2.10 2.05 2.05 2.024 1.993 1.89%
Adjusted Per Share Value based on latest NOSH - 259,377
30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 CAGR
RPS 159.14 155.02 155.98 151.88 158.64 159.27 157.96 0.49%
EPS 2.16 2.82 3.20 3.16 4.34 4.82 4.90 -42.04%
DPS 2.88 2.70 2.88 2.88 3.59 4.49 4.85 -29.32%
NAPS 0.369 0.3762 0.3777 0.3685 0.3686 0.3637 0.358 2.03%
Price Multiplier on Financial Quarter End Date
30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 CAGR
Date 29/09/17 30/06/17 31/03/17 30/12/16 30/09/16 30/06/16 31/03/16 -
Price 4.14 4.58 4.89 5.30 5.58 5.50 5.76 -
P/RPS 0.47 0.53 0.56 0.63 0.63 0.62 0.65 -19.42%
P/EPS 34.44 29.21 27.47 30.12 23.14 20.52 21.11 38.54%
EY 2.90 3.42 3.64 3.32 4.32 4.87 4.74 -27.90%
DY 3.86 3.28 3.27 3.02 3.58 4.55 4.69 -12.16%
P/NAPS 2.02 2.19 2.33 2.59 2.72 2.72 2.89 -21.22%
Price Multiplier on Announcement Date
30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 CAGR
Date 15/11/17 16/08/17 16/05/17 21/02/17 21/11/16 19/08/16 13/05/16 -
Price 3.82 4.19 4.72 5.05 5.70 5.62 5.60 -
P/RPS 0.43 0.49 0.54 0.60 0.65 0.63 0.64 -23.27%
P/EPS 31.78 26.73 26.52 28.70 23.64 20.97 20.52 33.82%
EY 3.15 3.74 3.77 3.48 4.23 4.77 4.87 -25.18%
DY 4.19 3.58 3.39 3.17 3.51 4.45 4.82 -8.90%
P/NAPS 1.86 2.00 2.25 2.46 2.78 2.78 2.81 -24.02%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment